Cardiovascular and cardiometabolic prevention: high-level priority in the era of COVID-19
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Viewpoint Source Type: research

Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19 cardiovascular complications
Coronavirus disease 2019 (COVID-19) has been declared a pandemic on 11 March 2020 by the WHO. Despite being mainly a respiratory virus, cardiac complications have been described. These range from sudden cardiac death to subtle diastolic dysfunction after recovery from COVID-19. The commonest cardiac presentation to date is acute heart failure resulting from biventricular or left ventricular hypokinesis and elevation of cardiac troponins. It has been shown that COVID-19 downregulates angiotensin-converting enzyme-2, which has protective effects on the endothelium and cardiomyocytes. It has also been proven that COVID-19 ind...
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Editorial Source Type: research

Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19
Coronavirus disease 2019 (COVID-19) is a serious illness that has rapidly spread throughout the globe. The seriousness of complications puts significant pressures on hospital resources, especially the availability of ICU and ventilators. Current evidence suggests that COVID-19 pathogenesis majorly involves microvascular injury induced by hypercytokinemia, namely interleukin 6 (IL-6). We recount the suggested inflammatory pathway for COVID-19 and its effects on various organ systems, including respiratory, cardiac, hematologic, reproductive, and nervous organ systems, as well examine the role of hypercytokinemia in the at-r...
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Review Source Type: research

Hypertension and diabetes mellitus in patients with COVID 19: a viewpoint on mortality
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Editorial Source Type: research

Obese communities among the best predictors of COVID-19-related deaths
Conclusion This article shows a tight correlation between average BMI, food supply per country, and COVID-19-related deaths. Such predisposing factors might operate by upregulating the inflammation pathway in heavily struck countries, leading to easier triggering of the infamous cytokine storm syndrome. Obesity also increases cardiovascular and respiratory morbidities, which are coupled to increased ICU demand and deaths among infected cases. Video abstract: http://links.lww.com/CAEN/A25. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Original Article Source Type: research

Introduction: cardiometabolic considerations in COVID-19
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Editorial Source Type: research

Nonalcoholic fatty liver disease: implications for endocrinologists and cardiologists
Type 2 diabetes mellitus is not just a risk factor but a progression factor for a plethora of multi-organ complications, including the liver and the vascular system. The profibrogenic-inflammatory liver disease nonalcoholic steatohepatitis affects patient’s mortality and overall cardiovascular and liver-related complications. There is an evident overlap between these diseases; therefore, there are important implications for endocrinologists, cardiologists, and hepatologists when treating these patients. In addition, as newly approved nonalcoholic steatohepatitis pharmacotherapy is expected to be available early this ...
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Reviews Source Type: research

Cardiometabolic disease in the older person: prediction and prevention for the generalist physician
Ageing is associated with chronic inflammation and oxidative stress that increase the risk of cardiovascular disease. Frailty and sarcopenia, which are associated with increased visceral obesity and muscle mass loss, are now emerging as new potential risk factors for cardiovascular disease. Increased muscle visceral fat leads to increased secretion of harmful proinflammatory adipokines and reduced muscle mass leads to reduced secretion of the protective myokines creating an abnormal cardiometabolic state increasing the risk of cardiovascular disease. This review: (1) explore traditional and newly emerging cardiometabolic r...
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Reviews Source Type: research

Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities
More than 100 million people in the USA have diabetes or prediabetes and are at high risk for developing cardiovascular disease. Current evidence-based guidelines support a multifactorial approach in patients with diabetes, including lifestyle intervention and pharmacological treatment of hyperglycemia, hypertension, and dyslipidemia. In addition, recent cardiovascular outcome trials demonstrated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists improve cardiovascular outcomes in patients with diabetes. Albeit this evidence, over 80% of patients with diabetes do not achieve the re...
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Reviews Source Type: research

Cardiometabolic medicine – the US perspective on a new subspecialty
The high prevalence of cardiovascular disease and worldwide diabetes epidemic has created an ever-increasing burden on the healthcare system. This calls for the creation of a new medicine subspecialty: cardiometabolic medicine. Using information from review articles listed on PubMed and professional society guidelines, the authors advocate for a cardiometabolic medicine specialization training program. The curriculum would integrate relevant knowledge and skills of cardiology and endocrinology as well as content of other disciplines essential to the optimal care of cardiometabolic patients, such as epidemiology, biostatist...
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Reviews Source Type: research

Preventive cardiology or cardiometabolic medicine: a new and emerging subspecialty?
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Editorials Source Type: research

The future of cardiovascular and metabolic medical practice: evidence-based winds of change
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - August 13, 2020 Category: Cardiology Tags: Editorials Source Type: research

A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics
Improvements in the medical management of heart failure have changed the course of the disease. However, mortality rates, hospitalization rates, and treatment costs are not at desired levels. Diuretics have been widely used in the treatment of congestion in heart failure patients. The following case reports represent a special patient group treated and followed by cardiology clinic. Treatment approach of each case report has been tailored on an individual basis depending on the clinical course and hospitalization rates of patients. Authors have highlighted and discussed the common aspects and future perspectives of their c...
Source: Cardiovascular Endocrinology - May 19, 2020 Category: Cardiology Tags: Case report Source Type: research

Relative frequency of cardiology vs. endocrinology visits by type 2 diabetes patients with cardiovascular disease in the USA: implications for implementing evidence-based use of glucose-lowering medications
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in type 2 diabetes (T2D) patients. Recent cardiovascular outcome trials demonstrated clear cardiovascular benefits of novel classes of glucose-lowering agents. We performed retrospective electronic health record review at two major healthcare systems in the USA to determine the relative frequencies of outpatient encounters (hence prescribing opportunities) that a patient with T2D and CVD had with a cardiologist vs. an endocrinologist over one-year period. Of 109 747 T2D patients, 42.6% had established CVD. The ratio of cardiology-to-endocrino...
Source: Cardiovascular Endocrinology - May 19, 2020 Category: Cardiology Tags: Short Report Source Type: research

Associations of adiponectin and leptin with brain natriuretic peptide in African Americans: the Jackson Heart Study
Conclusions Different linear associations of adiponectin and leptin with BNP were observed. Odds of elevated adiponectin were observed with elevated BNP in multivariate-adjusted models. This paradoxical relationship of adiponectin and plasma BNP is possibly explained through adiponectin resistance. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 19, 2020 Category: Cardiology Tags: Original Articles Source Type: research

Sociodemographic and metabolic risk characteristics associated with metabolic weight categories in the Women’s Health Initiative
Objective To identify sociodemographic and metabolic correlates of weight categories in postmenopausal women. Methods The Women’s Health Initiative enrolled 161 808 postmenopausal women ages 50–79. We included those free of cardiovascular disease (CVD) and with CVD risk factors and biomarkers (n = 19 412). Normal weight was defined as a BMI ≥18.5 and (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 19, 2020 Category: Cardiology Tags: Original Articles Source Type: research

A focused review of cardiovascular guideline related recommendations for the primary care physician in the USA
Primary care physicians in the USA serve the critical role of first contact for undiagnosed or mismanaged pathologies as well as providers of continuous care in multiple communities. Their scope of practice is broad from medication reconciliation to coordinating specialty care and even performing office procedures. Primary care physicians in the USA commonly encounter patients with diabetes and associated comorbidities related to prolonged insulin resistance. Mainly these include heart failure exacerbation or major adverse cardiovascular events. The demanding roles primary care physicians serve may render these providers e...
Source: Cardiovascular Endocrinology - May 19, 2020 Category: Cardiology Tags: Review Source Type: research

Ten tips for promoting your research
Publishing the results of scientific research is more than a personal choice; it is an ethical and increasingly regulatory obligation. It is generally accepted that top-ranking journals attract wider audiences than specialist publications and scientists have long recognised that the importance of targeting so-called high impact journal in getting their work noticed. However, gaining access to top-flight journals is difficult and a broader exposure is not necessarily guaranteed. Huge competition exists for attention within the scientific literature. Traditionally, scientists have viewed promoting their own research as somew...
Source: Cardiovascular Endocrinology - February 22, 2020 Category: Cardiology Tags: Viewpoint Source Type: research

Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarction
Introduction Acute hyperglycemia and contrast-induced nephropathy (CIN) are frequently observed in non-ST elevation myocardial infarction (NSTEMI) patients undergoing percutaneous coronary intervention (PCI), and both are associated with an increased mortality rate. We investigated the possible association between acute hyperglycemia and CIN in patients with NSTEMI undergoing PCI. Materials and methods We retrospectively enrolled 281(149, 53% men) NSTEMI patients undergoing PCI. For each patient, plasma glucose levels were secreened at hospital admission. Acute hyperglycemia was defined as glucose levels> 198&thins...
Source: Cardiovascular Endocrinology - February 22, 2020 Category: Cardiology Tags: Original Articles Source Type: research

Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetes
Conclusion Overall cost was higher for patients with DM, whether or not they were admitted with acute HF due to HFrEF or HFpEF. Cost per day alive for patients with DM continued to exceed corresponding costs for patients without DM, with HFpEF patients with DM having the highest cost. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - February 22, 2020 Category: Cardiology Tags: Original Articles Source Type: research

A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination Survey
Conclusion Applying diabetes treatment information from the National Health and Nutrition Examination Survey, as formulated in our treatment-based algorithm, may better identify type 1 and type 2 diabetes cases and thus prevent the specific biases imposed by conventional approaches which include the age of diabetes diagnosis as an initial criterion for diabetes type classification. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - February 22, 2020 Category: Cardiology Tags: Original Articles Source Type: research

Effects of aerobic and anaerobic exercise on glucose tolerance in patients with coronary heart disease and type 2 diabetes mellitus
Objectives In patients with coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM), physical activity is strongly advised as nonpharmacological therapy. In general, a moderate aerobic exercise intensity is recommended. It was also proposed, however, that greater intensities tend to yield even greater benefits in HbA1c. Hence, the most appropriate exercise intensity seems not to be established yet. We compared the effect of moderate (aerobic) and vigorous (anaerobic) activity on postprandial plasma glucose. Methods In 10 consecutive patients (63 ± 12 years, BMI 28.3 ±...
Source: Cardiovascular Endocrinology - February 22, 2020 Category: Cardiology Tags: Original Articles Source Type: research

Exercise prescription in patients with type 2 diabetes and coronary heart disease: could less be more?
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - February 22, 2020 Category: Cardiology Tags: Commentary Source Type: research

Ventricular fibrillation associated with Graves' disease and amiodarone induced thyrotoxicosis
This case involves a 55-year-old male patient with systolic heart failure and refractory atrial fibrillation due to thyrotoxicosis, who was electrically cardioverted but then developed torsade de pointes and ventricular fibrillation. Rate control was unsuccessful with digoxin, cardizem, labetalol, esmolol and amiodorone. Patient was externally cardioverted after which ECGs showed prolonged QT with frequent premature ventricular contractions. ECGs also showed ‘R-on-T' phenomenon leading to torsades and ventricular fibrillation. Atrial overdrive pacing was used to terminate the dangerous arrhythmia and the patient retu...
Source: Cardiovascular Endocrinology - November 8, 2019 Category: Cardiology Tags: Case Report Source Type: research

Left ventricular mass index and subendocardial myocardial function in children with chronic kidney disease, a transmural strain and three-dimensional echocardiographic study
This study has been conducted on 40 CKD patients (Group 1) and 40 age-matched controls, both groups were assessed by transmural echocardiography to determine the subepicardial and subendocardial global longitudinal strain (GLS) as an expression of the systolic function of each of those layers. LVH was assessed by calculation of left ventricle mass index (LVMI). Both groups underwent ambulatory blood pressure monitoring. Group 1 was assessed as regards lipid profile and insulin resistance by homeostasis model assessment of insulin resistance (HOMA-IR). Results HOMA-IR proved to be a more important determinant of LV hyper...
Source: Cardiovascular Endocrinology - November 8, 2019 Category: Cardiology Tags: Original Articles Source Type: research

The comparison of the relationships about the presence of branch retinal vein occlusion and endothelial functions between diabetic and non-diabetic patients
Objectives The aim of this study was to investigate the endothelial functions in both patients with diabetics and non-diabetics with branch retinal vein occlusion by using pulse wave analysis and flow-mediated dilatation methods. Patients and methods This cross-sectional study included a total of 136 participants (47 diabetic patients with branch retinal vein occlusion, 43 non-diabetic patients with branch retinal vein occlusion, and 46 otherwise healthy subjects). Evaluation of endothelial functions was performed by flow-mediated dilatation and pulse wave analysis methods. Stiffness index, reflection index (RI), and ...
Source: Cardiovascular Endocrinology - November 8, 2019 Category: Cardiology Tags: Original Articles Source Type: research

Estimation of apolipoprotein A in early onset ST-segment elevation myocardial infarction
This study sought to assess the apolipoprotein A in cohort of patients diagnosed with early onset acute ST-segment elevation myocardial infarction and to corelate it with major traditional cardiovascular risk factors. Methods A total of 50 such patients and 40 age and sex-matched healthy controls, both aged less than 50 years with their baseline demographic, clinical characteristics and cardiovascular risk factors were studied. Apolipoprotein A was estimated for all enrollees. Results The mean age of cases was 43.37 ± 5.85 years. The levels of apolipoprotein A among cases were not significantly lower compared ...
Source: Cardiovascular Endocrinology - November 8, 2019 Category: Cardiology Tags: Original Articles Source Type: research

Cardioprotective diabetes drugs: what cardiologists need to know
In patients with diabetes, where cardiovascular morbidity is highly prevalent, recent cardiovascular outcomes trials have identified therapies in the modern glucagon-like peptide 1 receptor agonist (GLP-1RA) and sodium-glucose cotransporter 2 inhibitor (SGLT2i) classes that significantly reduce cardiovascular events. A number of drugs in both classes have demonstrated reductions in the risk of the composite outcome of major adverse cardiovascular events (myocardial infarction, stroke, and cardiovascular death). In addition, SGLT2i drugs have a substantial impact on hospitalization for heart failure. Because GLP-1RA and SGL...
Source: Cardiovascular Endocrinology - November 8, 2019 Category: Cardiology Tags: Review Articles Source Type: research

Further insights into cardiovascular outcomes in diabetic and non-diabetic states: inhibition of sodium-glucose co-transports
Cardiovascular diseases are the leading cause of morbidity and mortality in the world. Diabetes increase heart disease related to death by two- to four-fold. SGLT2 inhibitors are new antidiabetic agents. The growing evidence of cardiovascular benefit of SGLT2 inhibitors independent of their effects on glycemic control is especially intriguing. Several clinical trials have shown that sotagliflozin (SGLT1-1/2 inhibitor) decreases body weight and reduces blood pressure in adults with T2D. A phase 3 study designed to evaluate cardiovascular outcomes of sotagliflozin is currently ongoing. Many pre-clinical studies were conducte...
Source: Cardiovascular Endocrinology - November 8, 2019 Category: Cardiology Tags: Review Articles Source Type: research

27th Annual Meeting of the European Group for the study of Insulin Resistance, Lisbon, Portugal, 8–9th May 2019
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - September 1, 2019 Category: Cardiology Tags: Short Report Source Type: research

Association of neutrophil-gelatinase-associated lipocalin with microvascular complications in patients with type 2 diabetes: a cross-sectional study
Conclusion There are controversial findings about the role of NGAL in diabetic patients in medical literature. Standard values of urine and serum NGAL levels have yet to be determined. Our study suggests that NGAL is not a useful marker to differentiate microalbuminuric patients from normoalbuminuric subjects. We also did not find a relationship between NGAL levels and the presence of retinopathy. Additional studies with larger sample sizes will be required to confirm or refute these findings. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - September 1, 2019 Category: Cardiology Tags: Original Articles Source Type: research

Relative fat mass is a better predictor of dyslipidemia and metabolic syndrome than body mass index
Background Relative fat mass (RFM) had been recently developed. We aimed to examine RFM predictability to various cardiometabolic risk factors, compared to BMI. Methods Observational, cohort study, among patients who visited the Rambam Periodic Examinations Institute (RPEI). We compared the correlation of BMI and RFM to hypertension, impaired fasting glucose, high LDL, low HDL and metabolic syndrome, by gender. Results During study years, 20 167 patients visited the RPEI and included in the trial. Compared to BMI, RFM showed significantly better predictability (odds ratio [OR], [95% confidence interval (CI), P valu...
Source: Cardiovascular Endocrinology - September 1, 2019 Category: Cardiology Tags: Original Articles Source Type: research

Association of lipid peroxidation and interleukin-6 with carotid atherosclerosis in type 2 diabetes
Aim Enhanced lipid peroxidation and elevated interleukin-6 levels are common in type 2 diabetes mellitus patients. Atherosclerotic vascular complications greatly contribute to morbidity and mortality in diabetes. The aim of this study was to assess the relation of lipid peroxidation and interleukin-6 with carotid atherosclerosis in type 2 diabetes mellitus. Methods This cross-sectional study included 90 type 2 diabetes mellitus male patients with age ≥ 40 years and 30 healthy male subjects matched for age. All of them were subjected to measuring of 8-iso prostaglandin F2α as a marker of lipid peroxidation, in...
Source: Cardiovascular Endocrinology - September 1, 2019 Category: Cardiology Tags: Original Articles Source Type: research

Addressing the impact of type 2 diabetes in ageing populations: the launch of the 2019 Endocrine Society Task Force Guideline
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - September 1, 2019 Category: Cardiology Tags: Commentary Source Type: research

Elizabeth Barrett-Connor (1935–2019): an appreciation
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - September 1, 2019 Category: Cardiology Tags: Appreciation Source Type: research

DiRECT and indirect paths to reducing cardiovascular risk in diabetes: insights from Diabetes UK 2019
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 2, 2019 Category: Cardiology Tags: Short Report Source Type: research

Correlation between the serum procalcitonin level and the extension and severity of coronary artery disease in patients with non-ST-segment elevation myocardial infarction
Conclusion The second 24-h postadmission serum PCT level was not correlated with the severity and extension of CAD according to the Gensini score in our patients with NSTEMI. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 2, 2019 Category: Cardiology Tags: Original Article Source Type: research

Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review
This review proposes that the development of the atherosclerotic plaque is critically dependent on its inflammatory components forming a self-perpetuating and propagating positive feedback loop. The components involved are: (1) LDL oxidation, (2) activation of the endothelium, (3) recruitment of inflammatory monocytes, (4) macrophage accumulation, which induces LDL oxidation, and (5) macrophage generation of inflammatory mediators, which also activate the endothelium. Through these stages, the positive feedback loop is formed, which generates and promotes expansion of the atherosclerotic process. To illustrate this dynamic...
Source: Cardiovascular Endocrinology - May 2, 2019 Category: Cardiology Tags: Review Source Type: research

Vascular disease and type 2 diabetes: the science policy case for early cardiometabolic intervention
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 2, 2019 Category: Cardiology Tags: Editorials Source Type: research

Cardiometabolic medicine: time to recognize a new clinical specialty?
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 2, 2019 Category: Cardiology Tags: Editorials Source Type: research

Vascular disease in the lower limb in type 1 diabetes
This review considers peripheral arterial disease (PAD) in the diabetic ischaemic lower limb including both macrovascular and microvascular aspects. The presentation of PAD is probably not significantly different in type 1 compared with type 2 diabetes. PAD in diabetic patients is diffuse and located distally being most severe in the crural and also the foot arteries. It is associated with arterial calcification and occlusion of the arteries rather than stenosis. Compared with the nondiabetic patient, PAD develops at a younger age, and women are equally affected as men. It is not known whether the presentation of ischaemic...
Source: Cardiovascular Endocrinology - March 1, 2019 Category: Cardiology Tags: Review articles Source Type: research

Type 1 diabetes mellitus and coronary revascularization
Over the last three decades, trials of coronary revascularization have taken into account whether populations did or did not have diabetes. What has not been considered is whether or not patients with diabetes in these studies have type 1 or type 2 diabetes. ‘Diabetes’ appears to be largely used as a synonym for type 2 diabetes. The number of patients with type 1 diabetes has not been reported in most trials. Many questions remain unanswered. Do patients with type 1 diabetes have the same response to various modes of revascularization as those with type 2 diabetes? We know type 2 diabetes affects coronary endot...
Source: Cardiovascular Endocrinology - March 1, 2019 Category: Cardiology Tags: Review articles Source Type: research

Cardiovascular disease in type 1 diabetes
Cardiovascular disease (CVD) is a well-recognized complication of diabetes. Although the association of type 2 diabetes with CVD has been well described, the mechanisms, risk stratification and screening strategies of CVD in type 1 diabetes (T1D) are less understood. This review aims to evaluate recent literature and guidelines regarding CVD in T1D. At the cellular level, the early stage of CVD is characterized by endothelial dysfunction. Recent studies have shown that endothelial function is unaffected in younger T1D patients but there is a significant degree of endothelial dysfunction in the older T1D population compared...
Source: Cardiovascular Endocrinology - March 1, 2019 Category: Cardiology Tags: Review articles Source Type: research

The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it
The major cause of morbidity and often premature mortality in people with type I diabetes (T1D) is cardiovascular disease owing to accelerated atherosclerosis. We review publications relating to the rationale behind, and clinical tests for, detecting and treating early atherosclerosis in people with T1D. Currently available tools for atherosclerosis assessment include risk equations using vascular risk factors, arterial intima–media thickness, the ankle–brachial index, coronary artery calcification and angiography, and for more advanced lesions, intravascular ultrasound and optical coherence tomography. Evolvin...
Source: Cardiovascular Endocrinology - March 1, 2019 Category: Cardiology Tags: Review articles Source Type: research

Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburgh Epidemiology of Diabetes Complications study
Conclusion Despite declines in all-cause, cardiovascular and renal mortality in the total cohort, no improvements were observed in either mortality or complication incidence with a more recent onset in the examined cohort. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - March 1, 2019 Category: Cardiology Tags: Review articles Source Type: research

Cardiovascular disease in type 1 diabetes: the elephant in the clinic
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - March 1, 2019 Category: Cardiology Tags: Editorial Source Type: research

Abstracts
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - November 7, 2018 Category: Cardiology Tags: Abstracts: PDF Only Source Type: research

Association between thyroid abnormalities and hypertension among hospitalized US patients: data from the National Inpatient Sample
Abnormalities of thyroid, namely hyperthyroidism and hypothyroidism, are both associated with increased risk of hypertension. We utilized the National Inpatient Sample from the years 2012–2014 to explore the risk of thyroid disorders in relation to those without a thyroid diagnosis. We found that hypertension was more commonly associated with hyperthyroidism (odds ratio: 1.18; 95% confidence interval: 1.16–1.21, P (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - November 7, 2018 Category: Cardiology Tags: Short report Source Type: research

Vitamin D status in acute myocardial infarction: a case–control study
This study seeks the association between vitamin D deficiency and acute myocardial infarction (MI) in Iraq. Patients and methods A total of 104 patients with acute MI and 104 healthy controls were studied throughout 2015. Their demographic, cardiovascular risk factors, and clinical characteristics were recorded. Serum vitamin D measurement was carried out for all patients. Results Vitamin D was more deficient in cases than controls; the number of cases was 60 (57.7%) and 53 (51%), respectively. However, a statistically significant difference (P=0.6) was not obtained. In the patient group, type 2 diabetes mellitus sho...
Source: Cardiovascular Endocrinology - November 7, 2018 Category: Cardiology Tags: Original articles Source Type: research

Association between asymmetric dimethylarginine serum levels and left ventricular longitudinal deformation in patients with normal ejection fractions: a two-dimensional speckle-tracking echocardiography examination
Conclusion Our findings showed no statistically significant correlations between the serum ADMA level and the 2DSTE-derived indices of the longitudinal deformation of the LV myocardium in our nondiabetic patients without significant coronary artery stenosis and with normal LV ejection fractions. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - November 7, 2018 Category: Cardiology Tags: Original articles Source Type: research